Dexcom | Zinsaufwendungen Für Schuld

Aktienkurs
73.43
Täglich Wechseln
-0.95 -1.28%
Monatlich
0.10%
Jährlich
-16.91%
Q1 Prognose
71.16




Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 42M 2M 2025-12
Align Technology USD 2M 660K 2023-03
AtriCure USD 1.33M 17K 2025-09
Avanos Medical USD 1.9M 100K 2025-12
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Boston Scientific USD 90M 3M 2025-12
Cooper Companies USD 24.4M 1000K 2025-09
Dexcom USD 4.7M 0 2025-09
Edwards Lifesciences USD 38.6M 1.2M 2025-09
Globus Medical USD 5.1B 5.1B 2025-09
Hologic USD 27.6M 1000K 2025-12
Inogen 1.03M 384K 2025-03
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
J&J USD 18M 290M 2025-09
Masimo USD 8.8M 600K 2025-09
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.36M 390K 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Solventum Corp USD 51M 13.92B 2025-12
Stryker USD 157M 46.17B 2025-09
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
West Pharmaceutical Services USD 200K 100K 2025-09
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12


Dexcom Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.